Författare: Olsson Karin, Öhlin Bertil

Titel: ABC om hyponatremi (serie: Medicinens ABC) 2012 nr 17 sid 888-92

Läs/ladda hem artikeln:
Översikt
Fullständig referenslista
Artikeln i pdf-format
Artikeln i webbversion
Sid 888
Sid 889
Sid 890
Sid 891
Sid 892
Om Läkartidningens fulltext på Internet
Ämnesord:
Hyponatremi
SIADH
Vätske- och elektrolytbalans
Vasopressiner
Demyeliniserande sjukdomar
Saltlösning, hyperton















Sök liknande artiklar

Referenser:
Referenser
1. Stockand J. Vasopressin regulation of renal sodium excretion. Kidney Int. 2010;78:849-56.
2. Hall JE, Guyton AC. Textbook of medical physiology. 10th edition. Philadelphia: Elsevier; 2000. p 323-8.
3. Kazory A. Hyponatremia in heart failure: Revisiting pathophysiology and therapeutic strategies. Clin Cardiol. 2010;33(6)322-9.
?4. Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342(21):1581-9.
?5. Liamis GL, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008;52(1):144-53.
6. Hannon MJ, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences. Eur J Endocrinol. 2010;162 Suppl 1:S5-12.
7. Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356(20):2064-72.
8. Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta. 2003;337:169-72.
?9. Upadhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia. Am J Med. 2006;119(7 Suppl 1):S30-5.
10. Shapiro DS, Sonnenblick M, Galperin I, et al. Severe hyponatremia in elderly hospitalized patients: prevalence, aetiology and outcome. Intern Med J. 2010;40:574-80.
11. Renneboog B, Musch W, Vandemergel X, et al. Mild chronic hyponatremia is associated with falls, unsteadiness and attention deficits. Am J Med. 2006;119(1):71.e1-8.
12. Gankam KF, Andres C, Sattar L, et al. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM. 2008;101:583-8.
13. Verbalis JG, Barsony J, Sugimura Y, et al. Hyponatremia-induced osteoporosis. J Bone Miner Res. 2010;25(3):554-63.
14. Moritz LM, Ayus JC. The pathophysiology and treatment of hyponatraemic encephalopathy: an update. Nephrol Dial Transplant. 2003;18(12):2486-91.
15. Patel GP, Balk RA. Recognition and treatment of hyponatremia in acutely ill hospitalized patients. Clin Ther. 2007;29(2):211-29.
16. Laureno R, Karp BI. Myelinolysis after correction of hyponatremia. Ann Intern Med. 1997;126(1):57-62.
17. Menger H, Jörg J. Outcome of central pontine and extrapontine myelinolysis. J Neurol. 1999;246(8):700-5.
18. Brunner JE, Redmond JM, Haggar AM, et al. Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study. Ann Neurol. 1990;27(1):61-6.
19. Utvecklade central pontin myelinolys efter alltför snabb korrigering av hyponatremi. Risken inte tillräckligt känd i vården. Läkartidningen. 2008;105:1690.
20. Sterns RH, Cappuccio JD, Silver SM, et al. Neurologic sequelae after treatment of severe hyponatremia: A multicenter perspective. J Am Soc Nephrol. 1994;4(8):1522-30.
21. Verbalis JG, Goldsmith SR, Greenberg A, et al. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. 2007;120(11 Suppl 1):S1-21.
22. Karp BI, Laureno R. Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia. Medicine. 1993;72(6):359-73.
23. Gankam KF, Soupart A, Pochet R, et al. Re-introduction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats. Kidney Int. 2009;76(6):614-21.
24. Soupart A, Ngassa M, Decaux G. Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia. Clin Nephrol. 1999;51(6):383-6.
25. Perianayagam A, Sterns RH, Silver SM, et al. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin J Am Soc Nephrol. 2008;3(2):331-6.
26. Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate and severe hyponatremia. Am J Med. 2009;122(9):857-65.
27. Clayton JA, Le Jeune IR, Hall IP. Severe hyponatremia in medical in-patients: aetiology, assessment and outcome. QJM. 2006;99(8):505-11.
28. Mohammed AA, van Kimmenade RR, Richards M, et al. Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study. Circ Heart Fail. 2010;3(3):354-61.
29. Klopotowski M, Kruk M, Przyluski J, et al. Sodium level on admission and in-hospital outcomes of STEMI patients treated with primary angioplasty: The ANIN Myocardial Infarction Registry. Med Sci Monit. 2009;15(9):CR477-83.
30. Borroni G, Maggi A, Sangiovanni A, et al. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Digest Liver Dis. 2000;32(7):605-10.
31. Milionis HJ, Liamis GL, Elisaf MS. The hyponatremic patient: a systematic approach to laboratory diagnosis. CMAJ. 2002;166(8):1056-62.
32. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: Evaluating the correction factor for hyperglycemia. Am J Med. 1999;106(4):399-403.
33. Chantzichristos D, Drougge H, Dahm P, et al. Svenskt vårdprogram för hyponatremi. Svenska endokrinologföreningen och Svensk förening för anestesi och intensivvård. 13 sep 2011. http://www3.svls.se/sektioner/endokrin/documents/Svenskt%20vardprogram%20for%20hyponatremi_120120.pdf
34. Moritz ML, Ayus JC. 100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy. Metab Brain Dis. 2010;25:91-6.
35. Sterns RH, Nigweaker SU, Hix JK. The treatment of hyponatremia. Semin Nephrol. 2009;29:282-99.
36. Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;335:2099-112.
37. Furst H, Hallows K, Post J, et al. The urine/plasma electrolyte ratio: A predictive guide to water restriction. Am J Med Sci. 2000;319(4):240-4.